We are thrilled to announce that Constructive Bio has successfully raised $58 million in our latest funding round, signaling a significant step forward in our mission to revolutionize biological engineering. Emerging from the esteemed laboratory of Professor Jason Chin at the MRC Laboratory of Molecular Biology in Cambridge, Constructive Bio harnesses the power of precise DNA sequence design to usher in a new era of biological manipulation. Our pioneering technology enables us to fundamentally reprogram the genetic code, allowing us to synthesize molecules and genetic sequences that nature has yet to produce. With this substantial investment, we aim to accelerate our development efforts in creating innovative classes of enzymes, pharmaceuticals, and biomaterials, paving the way for groundbreaking advancements in various industries, including medicine and sustainable materials. The funding will facilitate the expansion of our research team, bolster our state-of-the-art facilities, and advance the commercialization of our platform. As we embark on this exciting journey, we invite passionate and driven individuals to join our team and contribute to a future where biological systems are tailored to meet global challenges. Constructive Bio is not just about creating new molecules; it’s about reshaping the very fabric of what is biologically possible. Stay tuned for updates as we continue to break barriers and transform the world through mindful biological innovation!










.png&w=3840&q=75)


